Bone Growth Stimulators Market by Product (Stimulation Device [External, Ultrasonic, Implantable], Bone Morphogenetic Proteins, Platelet Rich Plasma), Application (Spinal Fusion, Fracture, Oral Surgeries), End User (Hospital, ASC) - Global Forecast to 2030

The Bone Growth Stimulators Market is projected to reach $1.94 billion by 2030, at a CAGR of 4.9% from 2023 to 2030.

Bone growth stimulators improve the body’s bone healing process in patients undergoing bone fusion surgeries. These stimulators can be worn outside or used during implantation therapies such as Cardiac Resynchronization Therapy (CRT) and Implantable Cardioverter-Defibrillator (ICD). It can heal bone fractures by applying electrical or ultrasound waves. This non-invasive bone healing treatment method is used as an alternative to bone grafts.

The growth of this market is driven by the increasing preference for minimally invasive treatments, rising cases of bone fractures and spinal injuries, increasing geriatric population and subsequent increase in the cases of orthopedic diseases and injuries, and growing incidences of sports injuries. In addition, the growing number of hospitals and surgical centers worldwide, increasing utilization of platelet-rich plasma (PRP) in other applications, and emerging economies offer opportunities for the growth of this market.

Increasing Geriatric Population and Subsequent Increase in Orthopedic Diseases and Injuries to Drive the Demand for Bone Growth Stimulators Market

According to the United Nations Population Funds (UNFPA), the geriatric population has been growing at a faster rate in the past few years. Globally, the population aged 80 years or over is growing more rapidly than the younger population.

According to the data published by the United Nations (UN) Department of Economic and Social Affairs, the number of older people aged 65 years or over was 761 million in 2021. This number is expected to reach 1.6 billion by 2050. The number of people aged 80 years or over is growing rapidly. This growth is mainly attributed to increasing life expectancy, improvements in healthcare facilities, and declining fertility and mortality rates. According to data published by the Multidisciplinary Digital Publishing Institute (MDPI), hip fractures are expected to increase by 89% by 2025 globally compared to 2000, with nearly 800,000 fractures annually.

Furthermore, the population aged 50 and above is highly prone to orthopedic diseases, resulting in impaired posture and static & dynamic foot problems. By 2050, 130 million people will suffer from osteoarthritis worldwide, of which 40 million will be severely affected. (Source: The Modern Academic Journal Management System).

Thus, the growing geriatric population and the subsequent increase in the prevalence of orthopedic diseases are expected to drive the growth of the bone growth stimulators market during the forecast period.

Click here to: Get a Free Sample Copy of this report

Increasing Preference for Stimulation Treatments to Drive the Demand for Bone growth stimulators market

Standard bone fracture management includes stabilization of the fracture site by internal or external fixation devices, compression devices or casting. Many factors can cause delayed union or non-union; however, diagnosis of the fracture depends on the pain and motion at the fracture site. Bone healing can be induced or enhanced through bone grafting or stimulators. The preference for stimulation treatments has been increasing in the last few years to overcome the drawbacks of bone graft surgeries. Bone graft surgeries may lead to an increase in the time for treatment and healing. It increases postoperative care and the need for multiple therapies.

Furthermore, the use of bone graft surgeries increases the cost of treatment. The average price for basic augmentation for a dental bone graft was around $200 to $1,200 for a single bone graft area in 2021. The cost of auto bone graft is much higher since it has two surgical sites. Moreover, patients also need to pay additional fees for other procedures, such as hospital admission, x-rays, and anesthesia. In addition, using bone grafts increases bone morbidity and disease transfer risk and may lead to immune-mediated rejection. It increases technical difficulties and postoperative bleeding, and there is a high chance of dehydration, impairing the stability of bone repair. Hence, surgeons prefer bone growth stimulators as they are convenient, easy to use, less complicated, non-operative, non-invasive, and have no risk of immunologic complications.  Additionally, bone morphogenetic proteins (BMPs) serve as an alternative to autografts in some surgeries.

Thus, to reduce the risk associated with bone graft surgeries, the adoption of bone growth stimulators is increasing, subsequently driving the market’s growth.

Key Findings in the Bone Growth Stimulators Market Study:

In 2023, the bone growth stimulation devices segment is expected to account for the largest share of the market

Based on product, in 2023, the bone growth stimulation devices segment is expected to account for the largest share of the bone growth stimulators market. The large market share of this segment is attributed to the increasing prevalence of non-union bone fractures and the growing preference for non-surgical treatment procedures. Bone growth stimulation devices are non-invasive and help promote healing after spinal fusion fractures or surgeries. These devices are often used to treat non-union bone fractures.

In 2023, Spinal Fusion Surgeries Segment is expected to account for the largest share of the market

Based on the application, the bone growth stimulators market is segmented into spinal fusion surgeries, delayed union & non-union bone fractures, oral and maxillofacial surgeries, and other applications. In 2023, the spinal fusion surgeries segment is expected to account for the largest share of the bone growth stimulators market. The large market share of this segment is attributed to the rise in spinal fusion surgeries, technological advancements in spinal surgery, and the high incidence rate of degenerative spinal disorders and conditions and obesity.

Based on end user, in 2023, the hospitals & specialized clinics segment is expected to account for the largest share of the bone growth stimulators market

Based on end-user, in 2023, the hospitals & specialized clinics segment is expected to account for the largest share of the bone growth stimulators market. The large market share of this segment is attributed to increasing government and private organizations’ initiatives to increase and improve hospitals and specialized clinics and the continuous increase in the number of spinal fusion and orthopedic surgeries performed in hospital settings.

North America to Dominate the Market in 2023

In 2023, North America is expected to account for the largest share of the bone growth stimulators market. North America’s major market share is mainly attributed to the availability of advanced technologies and the high adoption rate of innovative products in the healthcare sector in the region. Additionally, the increasing healthcare expenditures, the growing elderly population, and the rising incidence & prevalence of musculoskeletal diseases contribute to the growth of this regional market.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market participants between 2020 and 2022. The key players profiled in the bone growth stimulators market report are Orthofix Medical Inc.(U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Medtronic, plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson Private Limited (U.S.), DJO, LLC (U.S.), Bioventus LLC (U.S.), OssaTechnics BV (Germany), Arthrex GmbH (U.S.), Smith & Nephew plc (U.K.), and ITO CO., Ltd. (Japan).

Scope of the Report:

Bone Growth Stimulators Market, by Product

• Bone Growth Stimulation Devices
  • External Bone Growth Stimulators
    • Capacitive Coupling (CC) Devices Hair Sprays
    • Combined Magnetic Field Devices (CMF)
    • Pulsed Electromagnetic Field Devices (PEMF)
  • Ultrasonic Bone Growth Stimulators
  • Implantable Bone Growth Stimulators
• Bone Morphogenetic Proteins (BMP)
• Platelet-Rich Plasma (PRP)

Bone Growth Stimulators Market, by Application

• Spinal Fusion Surgeries
• Delayed Union & Non-union Bone Fractures
• Oral and Maxillofacial Surgeries
• Other Applications
  (Note: Other applications include Pediatric Orthopedic Surgeries and Knee replacement or arthroscopic surgeries.)

Bone Growth Stimulators Market, by End User

• Hospitals & Specialized Clinics
• Ambulatory Surgery Centers
• Other End Users
  (Note: Other end-users include Academic & Research Institutes and Home Care.)

Bone Growth Stimulators Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

Key questions answered in the report: